Chemicals News and Research

RSS

Breakthrough HIV research wins prestigious industry award

Research that could lead to a breakthrough in the treatment of HIV has scooped a University of Manchester scientist a prestigious industry award.

From The University of Manchester 23 Nov 2004

New antidotes for organophosphates are needed to prepare for chemical attacks in the West

Organophosphates are a group of organic compounds containing phosphorus, some of which are used as pesticides. Organophosphates have also been used in chemical weapons and nerve gas attacks, such as the sarin attack in Japan.

18 Nov 2004

Eating apples may protect against Alzheimer's and Parkinsonism

A group of chemicals in apples could protect the brain from the type of damage that triggers such neurodegenerative diseases as Alzheimer's and Parkinsonism, according to two new studies from Cornell University food scientists.

18 Nov 2004

What makes beer taste so darn good to men, but vile to most women?

What makes beer taste so darn good to men, but vile to most women? Some oral sensations are under genetic control and new research suggests that these influences on taste perception could help determine the risk of excess alcohol consumption.

16 Nov 2004

Cotinine not linked to hearing loss

Levels of cotinine, a chemical that is made by the body from nicotine, which is found in cigarette smoke, does not appear to be linked to hearing loss, according to an article in the November issue of The Archives of Otolaryngology – Head & Neck Surgery.

16 Nov 2004

Scientists and clinicians are pioneering the diagnosis and treatment of children's brain tumours

The University of Birmingham, England, is working with Birmingham Children's Hospital to use high-tech science to make a difference to children's lives.

11 Nov 2004

Neogen Europe have announced new tests to detect hazardous toxins in grains, wine, nuts and coffee

Neogen Europe Ltd. announced today the introduction of two new tests to detect hazardous toxins in grains, wine, nuts and coffee. Marketing has begun in Europe and the products will soon be available in the United States and other worldwide markets.

8 Nov 2004

Tiny, vibrating paddle oscillator senses the mass of a virus

By using a device only six-millionths of a meter long, researchers at Cornell University have been able to detect the presence of as few as a half-dozen viruses -- and they believe the device is sensitive enough to notice just one.

5 Nov 2004

Researchers have identified a protein that transports the essential nutrient boron into cells

Researchers at UT Southwestern Medical Center at Dallas have identified a protein that transports the essential nutrient boron into cells, where it is important for cell growth and bone development. The findings are in the Nov. 5 edition of the journal Molecular Cell and are online.

5 Nov 2004

Ecstasy use down among America's youth

The Substance Abuse and Mental Health Services Administration's (SAMHSA's) just-released 2003 National Survey on Drug Use and Health (NSDUH) reports the number of current ecstasy users decreased between 2002 and 2003, from 676,000 (0.3 percent) to 470,000 (0.2 percent).

4 Nov 2004

Sensor protein that identifies DNA breaks and activates the p53 cell-death program has been identified

DNA breaks from radiation, toxic chemicals, or other environmental causes occur routinely in cells and, unless promptly and properly repaired, can lead to cancer-causing mutations.

4 Nov 2004

STAT3 protein could lead to new ways to prevent skin cancer

Scientists at The University of Texas M. D. Anderson Cancer Center have identified a protein that serves as a master regulator of skin cancer - a finding that could lead to new ways to prevent skin cancer before it starts.

4 Nov 2004

Reproductive hormones have effects on all of these stages of brain growth and development

Scientists are now uncovering increasing evidence that the brain not only responds to hormones produced by the reproductive system, but that these hormones-the so-called "female hormones," estrogen and progestin, and the "male" androgens, such as testosterone-play an important role in the development of differences between male and female brains.

2 Nov 2004

Marijuana-like compounds may aid Parkinson's disease, pain and obesity

No longer a pipe dream, new animal research now indicates that marijuana-like compounds can aid a bevy of debilitating conditions, ranging from brain disorders such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease, to pain and obesity.

28 Oct 2004

Smoking shown to quell painful sensations and heighten positive emotions

Smokers often say that lighting up a cigarette can calm their nerves, satisfy their craving and help them relax.

28 Oct 2004

Researchers have identified a protein in the brain that halts the progression of Alzheimer's

Researchers have identified a protein in the brain that halts the progression of Alzheimer's disease in human brain tissue. The protein, known as "transthyretin," protects brain cells from gradual deterioration by blocking another toxic protein that contributes to the disease process.

25 Oct 2004

Can traditional Chinese medicine relieve symptoms of menopause

A woman experiencing the odd hot flush when glimpsing Brad Pitt decked out in his 'Troy' gear might be normal, but uncontrolled flushing because of menopause usually isn't so welcome.

25 Oct 2004

Allopurinol, a common gout drug may also offer some protection against colorectal cancer

A commonly prescribed drug used to treat gout may also offer some protection against colorectal cancer, according to a new study from researchers at the University of Michigan and in Israel.

25 Oct 2004

Microcrustaceans defeat dengue fever

Dengue fever causes 50 million infections annually in more than 90 countries; however this may soon become a thing of the past, as QIMR broadens its successful and totally environmentally-friendly mosquito-breeding control programs against dengue fever.

22 Oct 2004

Atypical antipsychotics commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance

Researchers from the Johns Hopkins Children's Center say a group of drugs known as "atypical antipsychotics" that are commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance, a condition that increases the risk of developing Type 2 diabetes and heart disease later in life.

21 Oct 2004

Chemicals News and Research

Breakthrough HIV research wins prestigious industry award

New antidotes for organophosphates are needed to prepare for chemical attacks in the West

Eating apples may protect against Alzheimer's and Parkinsonism

What makes beer taste so darn good to men, but vile to most women?

Cotinine not linked to hearing loss

Scientists and clinicians are pioneering the diagnosis and treatment of children's brain tumours

Neogen Europe have announced new tests to detect hazardous toxins in grains, wine, nuts and coffee

Tiny, vibrating paddle oscillator senses the mass of a virus

Researchers have identified a protein that transports the essential nutrient boron into cells

Ecstasy use down among America's youth

Sensor protein that identifies DNA breaks and activates the p53 cell-death program has been identified

STAT3 protein could lead to new ways to prevent skin cancer

Reproductive hormones have effects on all of these stages of brain growth and development

Marijuana-like compounds may aid Parkinson's disease, pain and obesity

Smoking shown to quell painful sensations and heighten positive emotions

Researchers have identified a protein in the brain that halts the progression of Alzheimer's

Can traditional Chinese medicine relieve symptoms of menopause

Allopurinol, a common gout drug may also offer some protection against colorectal cancer

Microcrustaceans defeat dengue fever

Atypical antipsychotics commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News